Reaction Details |
| Report a problem with these data |
Target | Neuropeptide Y receptor type 5 |
---|
Ligand | BDBM50249833 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_498773 (CHEMBL1021965) |
---|
Ki | 1.4±n/a nM |
---|
Citation | Sato, N; Ando, M; Ishikawa, S; Jitsuoka, M; Nagai, K; Takahashi, H; Sakuraba, A; Tsuge, H; Kitazawa, H; Iwaasa, H; Mashiko, S; Gomori, A; Moriya, R; Fujino, N; Ohe, T; Ishihara, A; Kanatani, A; Fukami, T Discovery of tetrasubstituted imidazolines as potent and selective neuropeptide Y Y5 receptor antagonists: reduced human ether-a-go-go related gene potassium channel binding affinity and potent antiobesity effect. J Med Chem52:3385-96 (2009) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Neuropeptide Y receptor type 5 |
---|
Name: | Neuropeptide Y receptor type 5 |
Synonyms: | NPY-Y5 | NPY-Y5 receptor | NPY5-R | NPY5R | NPY5R_HUMAN | NPYR5 | NPYY5 | Neuropeptide Y receptor type 5 | Neuropeptide Y receptor type 5 ( NPY Y5) | Y5 receptor |
Type: | Enzyme |
Mol. Mass.: | 50746.64 |
Organism: | Homo sapiens (Human) |
Description: | Q15761 |
Residue: | 445 |
Sequence: | MDLELDEYYNKTLATENNTAATRNSDFPVWDDYKSSVDDLQYFLIGLYTFVSLLGFMGNL
LILMALMKKRNQKTTVNFLIGNLAFSDILVVLFCSPFTLTSVLLDQWMFGKVMCHIMPFL
QCVSVLVSTLILISIAIVRYHMIKHPISNNLTANHGYFLIATVWTLGFAICSPLPVFHSL
VELQETFGSALLSSRYLCVESWPSDSYRIAFTISLLLVQYILPLVCLTVSHTSVCRSISC
GLSNKENRLEENEMINLTLHPSKKSGPQVKLSGSHKWSYSFIKKHRRRYSKKTACVLPAP
ERPSQENHSRILPENFGSVRSQLSSSSKFIPGVPTCFEIKPEENSDVHELRVKRSVTRIK
KRSRSVFYRLTILILVFAVSWMPLHLFHVVTDFNDNLISNRHFKLVYCICHLLGMMSCCL
NPILYGFLNNGIKADLVSLIHCLHM
|
|
|
BDBM50249833 |
---|
n/a |
---|
Name | BDBM50249833 |
Synonyms: | 6-[(4S,5S)-4-(4-Fluorophenyl)-4-(6-fluoro-3-pyridyl)-5-methyl-4,5-dihydro-1H-imidazol-2-yl]-2(1H)-pyridinone | CHEMBL489726 |
Type | Small organic molecule |
Emp. Form. | C20H16F2N4O |
Mol. Mass. | 366.364 |
SMILES | C[C@@H]1NC(=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1)c1cccc(=O)[nH]1 |r,c:3| |
Structure |
|